Mackenzie Financial
BNGO icon

Mackenzie Financial’s Bionano Genomics BNGO Stock Holding History

Mackenzie Financial’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-32
Closed -$21.5K – 1522
2023
Q1 		$21.5K Hold
32
– – ﹤0.01% 1480
2022
Q4 		$28.3K Hold
32
– – ﹤0.01% 1384
2022
Q3 		$36K Sell
32
-3
-9% -$3.96K ﹤0.01% 1382
2022
Q2 		$29K Buy
35
+7
+25% +$7.2K ﹤0.01% 1418
2022
Q1 		$43K Buy
28
+2
+8% +$2.7K ﹤0.01% 1374
2021
Q4 		$46K Sell
26
-2
-7% -$5.35K ﹤0.01% 1403
2021
Q3 		$91K Buy
+28
New +$97.9K ﹤0.01% 1376

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mackenzie Financial's BNGO Position: Q2 2023 in Review

Mackenzie Financial sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 32 shares — an estimated $21.5K sold.

Mackenzie Financial first reported a position in BNGO in Q3 2021 and held it in 7 quarters. The position peaked at $91K in Q3 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Mackenzie Financial reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Mackenzie Financial sold 32 Bionano Genomics shares in Q2 2023, an estimated $21.5K.
  • Mackenzie Financial first reported a position in Bionano Genomics in Q3 2021 and held it in 7 quarters.
  • Mackenzie Financial's Bionano Genomics position peaked at $91K in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Mackenzie Financial's 13F filing for Q2 2023, filed 3 Aug 2023.